Parametric Portfolio Associates’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$5.31M Buy
245,147
+21,231
+9% +$461K ﹤0.01% 1818
2021
Q4
$6.22M Buy
223,916
+16,806
+8% +$407K ﹤0.01% 1705
2021
Q3
$4.4M Buy
207,110
+49,335
+31% +$925K ﹤0.01% 1924
2021
Q2
$2.6M Buy
157,775
+104,485
+196% +$1.6M ﹤0.01% 2288
2021
Q1
$666K Buy
53,290
+5,342
+11% +$56.6K ﹤0.01% 3349
2020
Q4
$425K Buy
47,948
+5,718
+14% +$46.5K ﹤0.01% 3445
2020
Q3
$274K Buy
42,230
+1,212
+3% +$7.68K ﹤0.01% 3527
2020
Q2
$253K Sell
41,018
-213,946
-84% -$1.31M ﹤0.01% 3544
2020
Q1
$1.72M Buy
254,964
+107,688
+73% +$1.02M ﹤0.01% 2481
2019
Q4
$1.71M Buy
147,276
+23,965
+19% +$271K ﹤0.01% 2787
2019
Q3
$1.27M Buy
123,311
+2,790
+2% +$27.4K ﹤0.01% 2899
2019
Q2
$1.13M Buy
120,521
+41,289
+52% +$318K ﹤0.01% 2993
2019
Q1
$557K Sell
79,232
-4,956
-6% -$42.5K ﹤0.01% 3277
2018
Q4
$617K Sell
84,188
-29
-0% -$243 ﹤0.01% 3219
2018
Q3
$735K Buy
84,217
+35,138
+72% +$359K ﹤0.01% 3259
2018
Q2
$552K Buy
49,079
+1,313
+3% +$15.7K ﹤0.01% 3304
2018
Q1
$531K Buy
47,766
+3,704
+8% +$46.4K ﹤0.01% 3322
2017
Q4
$562K Sell
44,062
-8,888
-17% -$117K ﹤0.01% 3272
2017
Q3
$753K Buy
52,950
+5,248
+11% +$65.7K ﹤0.01% 3192
2017
Q2
$616K Buy
47,702
+3,182
+7% +$41K ﹤0.01% 3239
2017
Q1
$639K Buy
44,520
+2,525
+6% +$37.2K ﹤0.01% 3089
2016
Q4
$656K Sell
41,995
-11,185
-21% -$153K ﹤0.01% 3049
2016
Q3
$626K Buy
53,180
+15,685
+42% +$207K ﹤0.01% 3063
2016
Q2
$522K Sell
37,495
-66,332
-64% -$879K ﹤0.01% 3165
2016
Q1
$1.21M Buy
103,827
+5,352
+5% +$68K ﹤0.01% 2791
2015
Q4
$1.61M Sell
98,475
-21,398
-18% -$340K ﹤0.01% 2404
2015
Q3
$1.63M Buy
119,873
+22,761
+23% +$309K ﹤0.01% 1989
2015
Q2
$1.23M Sell
97,112
-14,226
-13% -$161K ﹤0.01% 2643
2015
Q1
$1.32M Sell
111,338
-26,493
-19% -$304K ﹤0.01% 2566
2014
Q4
$1.72M Sell
137,831
-1,940
-1% -$19.8K ﹤0.01% 2322
2014
Q3
$1.3M Buy
139,771
+1,169
+0.8% +$8.96K ﹤0.01% 2476
2014
Q2
$904K Sell
138,602
-10,882
-7% -$71.9K ﹤0.01% 2788
2014
Q1
$1.21M Buy
149,484
+45,600
+44% +$449K ﹤0.01% 2518
2013
Q4
$1.04M Buy
103,884
+33,172
+47% +$230K ﹤0.01% 2638
2013
Q3
$427K Sell
70,712
-2,853
-4% -$16.3K ﹤0.01% 3193
2013
Q2
$380K Buy
+73,565
New +$377K ﹤0.01% 3159

Other funds holding CCRN

Parametric Portfolio Associates's CCRN Position: Q1 2022 in Review

Parametric Portfolio Associates increased its Cross Country Healthcare (CCRN) stake by 9.5% in Q1 2022, buying an estimated $461K and bringing the position to 245,147 shares worth $5.31M. The position accounts for ﹤0.01% of the portfolio, ranked #1818.

Parametric Portfolio Associates first reported a position in CCRN in Q2 2013 and has held it in 36 quarters since. The position peaked at $6.22M in Q4 2021. 195 funds tracked by Wall St. Rank hold CCRN as of Q1 2022.

  • Parametric Portfolio Associates held 245,147 shares of Cross Country Healthcare worth $5.31M as of Q1 2022.
  • Parametric Portfolio Associates bought 21,231 Cross Country Healthcare shares in Q1 2022, an estimated $461K.
  • Cross Country Healthcare made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #1818 holding.
  • Parametric Portfolio Associates first reported a position in Cross Country Healthcare in Q2 2013 and has held it in 36 quarters since.
  • Parametric Portfolio Associates's Cross Country Healthcare position peaked at $6.22M in Q4 2021.
  • 195 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.